Certain Stock Options of Prelude Therapeutics Incorporated are subject to a Lock-Up Agreement Ending on 17-AUG-2023. These Stock Options will be under lockup for 91 days starting from 18-MAY-2023 to 17-AUG-2023.

Details:
The directors, executive officers and certain of its affiliated stockholders have entered into lock-up agreements for a period of 90 days following this offering. The lock-up agreements are subject to various exceptions, and the company and its directors and executive officers may be released from the lock-up agreements prior to the expiration of the lock-up period at the sole discretion of Morgan Stanley & Co. LLC.